Contract research organization Pegasus Biotech Inc. is the latest bioscience company to join Emergence, Canada’s Bioscience Business Incubator. Founded in 2019, Pegasus Biotech is currently developing vaccines and biotherapeutics for the human and animal health sector and joins a cohort of 58 clients currently in the incubator program.
Pegasus Biotech is an agile biotech company that focuses on providing high quality vaccine and biotherapeutic development services to the human and animal health sector. They are also developing accurate and reliable analytical testing methods for the human and animal health industry.
Based in Charlottetown, PEI, their team is comprised of three senior scientists with a combined 50+ years of experience in the biotechnology industry and more than 30 years of management experience. Pegasus Biotech’s areas of expertise include cell culture/fermentation and purification process development, analytical assay development, human and veterinary biologic product development and regulatory submission, point-of-care and clinical diagnostic instrument and assay development, GLP/GMP lab quality standards and HSE.
“Our hope is that by leveraging the assistance offered by Emergence, that Pegasus can accelerate its journey to becoming a top-tier biotechnology CRO,” said Dan Wilson, Director of Operations, Pegasus Biotech.
Emergence is a business incubator dedicated to assisting start-ups and growth-stage bioscience companies in efficiently bringing their products and services to market. As part of the Emergence program, Pegasus Biotech will have access to business incubation services including:
Mentorship and advisory services: Emergence companies receive long-term expert advice from mentors, selected for their relevant experience, as well as services to fill in specific gaps in the company’s critical path.
Team Mentorship Program: The Critical Path Team Mentorship Program matches companies with skilled volunteer mentors to provide practical, day-to-day professional advice and business coaching.
Access to networks and resources: Emergence companies have access to networks including funding agencies, regulatory bodies, future talent, public organizations, service providers, investors, potential partners, and bioscience cluster companies.
For more information on Emergence, visit emergencebioincubator.com.